High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure

Mario Rotondi, Alberto Rosati, Andrea Buonamano, Laura Lasagni, Elena Lazzeri, Fabio Pradella, Vittorio Fossombroni, Calogero Cirami, Francesco Liotta, Giorgio La Villa, Mario Serio, Elisabetta Bertoni, Maurizio Salvadori, Paola Romagnani

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

In experimental models, the chemokine CXCL10/IP-10 is required for graft failure owing to both acute and chronic rejection. In the present study, pretransplantation sera from 316 cadaver kidney graft recipients were tested for serum CXCL10 and CCL22/MDC levels by an ELISA assay. Kidney graft recipients with normally functioning grafts showed significantly lower serum CXCL10 levels than patients who experienced graft failure, whereas no differences for serum CCL22 levels were observed. After the assignment of all patients to four groups according to serum CXCL10 levels, the death-censored survival rates of grafts were 97.5%, 93.6%, 89.7%, 78.7% (p = 0.0006) at 5 years, while no influence was observed on patient survival. Accordingly, patients with the highest CXCL10 levels showed an increased frequency and severity of rejection episodes. Serum C-reactive protein (CRP) level was also assayed in the same samples. Increase of serum CRP levels represented a predictive parameter for death, but not for graft failure. Multivariate analysis demonstrated that among the analyzed variables, CXCL10 had the highest predictive power of graft loss (RR 2.787). Thus, measurement of pretransplant serum CXCL10 levels might represent a clinically useful parameter to identify subjects who are at high risk of severe rejection and graft failure.

Original languageEnglish
Pages (from-to)1466-1474
Number of pages9
JournalAmerican Journal of Transplantation
Volume4
Issue number9
DOIs
Publication statusPublished - Sep 2004

Fingerprint

Renal Insufficiency
Allografts
Transplants
Serum
C-Reactive Protein
Blood Proteins
Chemokine CXCL10
Kidney
Graft Rejection
Cadaver
Theoretical Models
Multivariate Analysis
Survival Rate
Enzyme-Linked Immunosorbent Assay
Survival

Keywords

  • CXCR3
  • Graft failure
  • Graft outcome
  • IP-10
  • Rejection

ASJC Scopus subject areas

  • Immunology

Cite this

High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. / Rotondi, Mario; Rosati, Alberto; Buonamano, Andrea; Lasagni, Laura; Lazzeri, Elena; Pradella, Fabio; Fossombroni, Vittorio; Cirami, Calogero; Liotta, Francesco; La Villa, Giorgio; Serio, Mario; Bertoni, Elisabetta; Salvadori, Maurizio; Romagnani, Paola.

In: American Journal of Transplantation, Vol. 4, No. 9, 09.2004, p. 1466-1474.

Research output: Contribution to journalArticle

Rotondi, M, Rosati, A, Buonamano, A, Lasagni, L, Lazzeri, E, Pradella, F, Fossombroni, V, Cirami, C, Liotta, F, La Villa, G, Serio, M, Bertoni, E, Salvadori, M & Romagnani, P 2004, 'High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure', American Journal of Transplantation, vol. 4, no. 9, pp. 1466-1474. https://doi.org/10.1111/j.1600-6143.2004.00525.x
Rotondi, Mario ; Rosati, Alberto ; Buonamano, Andrea ; Lasagni, Laura ; Lazzeri, Elena ; Pradella, Fabio ; Fossombroni, Vittorio ; Cirami, Calogero ; Liotta, Francesco ; La Villa, Giorgio ; Serio, Mario ; Bertoni, Elisabetta ; Salvadori, Maurizio ; Romagnani, Paola. / High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. In: American Journal of Transplantation. 2004 ; Vol. 4, No. 9. pp. 1466-1474.
@article{22cdbc4d77b24ebcae99ce88646ffa7a,
title = "High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure",
abstract = "In experimental models, the chemokine CXCL10/IP-10 is required for graft failure owing to both acute and chronic rejection. In the present study, pretransplantation sera from 316 cadaver kidney graft recipients were tested for serum CXCL10 and CCL22/MDC levels by an ELISA assay. Kidney graft recipients with normally functioning grafts showed significantly lower serum CXCL10 levels than patients who experienced graft failure, whereas no differences for serum CCL22 levels were observed. After the assignment of all patients to four groups according to serum CXCL10 levels, the death-censored survival rates of grafts were 97.5{\%}, 93.6{\%}, 89.7{\%}, 78.7{\%} (p = 0.0006) at 5 years, while no influence was observed on patient survival. Accordingly, patients with the highest CXCL10 levels showed an increased frequency and severity of rejection episodes. Serum C-reactive protein (CRP) level was also assayed in the same samples. Increase of serum CRP levels represented a predictive parameter for death, but not for graft failure. Multivariate analysis demonstrated that among the analyzed variables, CXCL10 had the highest predictive power of graft loss (RR 2.787). Thus, measurement of pretransplant serum CXCL10 levels might represent a clinically useful parameter to identify subjects who are at high risk of severe rejection and graft failure.",
keywords = "CXCR3, Graft failure, Graft outcome, IP-10, Rejection",
author = "Mario Rotondi and Alberto Rosati and Andrea Buonamano and Laura Lasagni and Elena Lazzeri and Fabio Pradella and Vittorio Fossombroni and Calogero Cirami and Francesco Liotta and {La Villa}, Giorgio and Mario Serio and Elisabetta Bertoni and Maurizio Salvadori and Paola Romagnani",
year = "2004",
month = "9",
doi = "10.1111/j.1600-6143.2004.00525.x",
language = "English",
volume = "4",
pages = "1466--1474",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure

AU - Rotondi, Mario

AU - Rosati, Alberto

AU - Buonamano, Andrea

AU - Lasagni, Laura

AU - Lazzeri, Elena

AU - Pradella, Fabio

AU - Fossombroni, Vittorio

AU - Cirami, Calogero

AU - Liotta, Francesco

AU - La Villa, Giorgio

AU - Serio, Mario

AU - Bertoni, Elisabetta

AU - Salvadori, Maurizio

AU - Romagnani, Paola

PY - 2004/9

Y1 - 2004/9

N2 - In experimental models, the chemokine CXCL10/IP-10 is required for graft failure owing to both acute and chronic rejection. In the present study, pretransplantation sera from 316 cadaver kidney graft recipients were tested for serum CXCL10 and CCL22/MDC levels by an ELISA assay. Kidney graft recipients with normally functioning grafts showed significantly lower serum CXCL10 levels than patients who experienced graft failure, whereas no differences for serum CCL22 levels were observed. After the assignment of all patients to four groups according to serum CXCL10 levels, the death-censored survival rates of grafts were 97.5%, 93.6%, 89.7%, 78.7% (p = 0.0006) at 5 years, while no influence was observed on patient survival. Accordingly, patients with the highest CXCL10 levels showed an increased frequency and severity of rejection episodes. Serum C-reactive protein (CRP) level was also assayed in the same samples. Increase of serum CRP levels represented a predictive parameter for death, but not for graft failure. Multivariate analysis demonstrated that among the analyzed variables, CXCL10 had the highest predictive power of graft loss (RR 2.787). Thus, measurement of pretransplant serum CXCL10 levels might represent a clinically useful parameter to identify subjects who are at high risk of severe rejection and graft failure.

AB - In experimental models, the chemokine CXCL10/IP-10 is required for graft failure owing to both acute and chronic rejection. In the present study, pretransplantation sera from 316 cadaver kidney graft recipients were tested for serum CXCL10 and CCL22/MDC levels by an ELISA assay. Kidney graft recipients with normally functioning grafts showed significantly lower serum CXCL10 levels than patients who experienced graft failure, whereas no differences for serum CCL22 levels were observed. After the assignment of all patients to four groups according to serum CXCL10 levels, the death-censored survival rates of grafts were 97.5%, 93.6%, 89.7%, 78.7% (p = 0.0006) at 5 years, while no influence was observed on patient survival. Accordingly, patients with the highest CXCL10 levels showed an increased frequency and severity of rejection episodes. Serum C-reactive protein (CRP) level was also assayed in the same samples. Increase of serum CRP levels represented a predictive parameter for death, but not for graft failure. Multivariate analysis demonstrated that among the analyzed variables, CXCL10 had the highest predictive power of graft loss (RR 2.787). Thus, measurement of pretransplant serum CXCL10 levels might represent a clinically useful parameter to identify subjects who are at high risk of severe rejection and graft failure.

KW - CXCR3

KW - Graft failure

KW - Graft outcome

KW - IP-10

KW - Rejection

UR - http://www.scopus.com/inward/record.url?scp=4344648638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344648638&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2004.00525.x

DO - 10.1111/j.1600-6143.2004.00525.x

M3 - Article

VL - 4

SP - 1466

EP - 1474

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 9

ER -